T 1157/09 (Influenza vaccine/NOVARTIS VACCINES AND DIAGNOSTICS) of 17.01.2013
- European Case Law Identifier
- ECLI:EP:BA:2013:T115709.20130117
- Date of decision
- 17 January 2013
- Case number
- T 1157/09
- Petition for review of
- -
- Application number
- 97915628.8
- IPC class
- A61K 39/145C12N 7/00C12N 5/06
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
- Applicant name
- Novartis Vaccines and Diagnostics GmbH
- Opponent name
- GlaxoSmithKline Biologicals SA
Sanofi Pasteur SA
CRUCELL HOLLAND B.V.
SOLVAY PHARMACEUTICALS B.V.
Akzo Novel NV
Medimmune, Inc. - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Main request - requirements of the EPC met
- Catchword
- -
- Cited cases
- G 0002/10
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance with the order to maintain the patent based on claims 1 to 7 of the main request and pages 2 - 8 of the description, all filed at oral proceedings.